A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

2-Oxohistidine | CAS 265997-48-6 - Request Quote

Picture of 2-Oxohistidine

2-Oxohistidine

SZ CAT No:SZ-R017030
CAS No
265997-48-6
Mol.F.
C6H7N3O3
Mol.Wt.
169.1
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

2-Oxohistidine is chemically (S)-2-amino-3-(2-oxo-2H-imidazol-4-yl)propanoic acid. 2-Oxohistidine is supplied with detailed characterization data compliant with regulatory guideline. 2-Oxohistidine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 265997-48-6

Purchase 265997-48-6

Order 265997-48-6

Enquire 265997-48-6

price of 265997-48-6

265997-48-6 Supplier

265997-48-6 Manufacturer

265997-48-6 Exporter

buy high quality 2-Oxohistidine

Purchase 2-Oxohistidine

2-Oxohistidine suppliers

2-Oxohistidine manufacturers

2-Oxohistidine price

Order 2-Oxohistidine

Enquire 2-Oxohistidine

2-Oxohistidine cost

2-Oxohistidine Supplier

2-Oxohistidine Distributor

2-Oxohistidine for Method Validation

Rivaroxaban Reference Standard

2-Oxohistidine for ANDA Filing

2-Oxohistidine for Forced Degradation Studies

2-Oxohistidine Identification Standards

2-Oxohistidine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,